Workflow
Tuniu(TOUR)
icon
Search documents
Tuniu(TOUR) - 2024 Q1 - Earnings Call Transcript
2024-06-04 13:50
Tuniu Corporation (NASDAQ:TOUR) Q1 2024 Earnings Call Transcript June 4, 2024 8:00 AM ET Company Participants Mary Chen - Director of Investor Relations Donald Dunde Yu - Founder, Chairman and Chief Executive Officer Anqiang Chen - Financial Controller Conference Call Participants Operator Hello, and thank you for standing by for Tuniu's 2024 First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After management's prepared remarks, there will be a question-and-ans ...
Tuniu Announces Unaudited First Quarter 2024 Financial Results
Prnewswire· 2024-06-04 10:00
NANJING, China, June 4, 2024 /PRNewswire/ -- Tuniu Corporation (NASDAQ: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced its unaudited financial results for the first quarter ended March 31, 2024.Highlights for the First Quarter of 2024 Net revenues in the first quarter of 2024 increased by 70.9% year-over-year to RMB108.0 million (US$15.0 million[1]).Revenues from package tours in the first quarter of 2024 increased by 106.7% year-over-year to RMB83.0 mill ...
Tuniu to Report First Quarter 2024 Financial Results on June 4, 2024
prnewswire.com· 2024-05-20 06:00
NANJING, China, May 20, 2024 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced that it plans to release its unaudited financial results for the first quarter ended March 31, 2024, before the market opens on June 4, 2024.Tuniu's management will hold an earnings conference call at 8:00 am U.S. Eastern Time on June 4, 2024 (8:00 pm Beijing/Hong Kong Time on June 4, 2024).Listeners may access the call by dialing the foll ...
Tourmaline Bio Initiates Clinical Development of TOUR006 for Cardiovascular Diseases with First Patient Dosed in Phase 2 TRANQUILITY Trial
globenewswire.com· 2024-05-16 11:00
– First patient dosed in trial to evaluate the safety, pharmacokinetics and pharmacodynamics of TOUR006 in patients with inflammatory risk and chronic kidney disease – – Topline data anticipated in the first half of 2025 with potential to advance TOUR006 toward Phase 3 readiness for atherosclerotic cardiovascular disease (ASCVD) and other cardiovascular diseases – – TRANQUILITY trial intended to provide evidence of TOUR006’s best-in-class potential for ASCVD, including the potential for quarterly subcutaneo ...
Tuniu Corporation Files Its Annual Report on Form 20-F
Prnewswire· 2024-04-30 02:00
NANJING, China, April 29, 2024 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission. The annual report can be accessed on the Company's investor relations website at http://ir.tuniu.com or the SEC's website at www.sec.gov. The Company will provide a hard copy of its annual report containin ...
Tuniu(TOUR) - 2023 Q4 - Annual Report
2024-04-29 12:05
Table of Contents * Not for trading, but only in connection with the listing on The Nasdaq Global Market of American depositary shares. Securities registered or to be registered pursuant to Section 12(g) of the Act. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal y ...
Tuniu(TOUR) - 2023 Q4 - Earnings Call Transcript
2024-03-13 14:18
Tuniu Corporation (NASDAQ:TOUR) Q4 2023 Earnings Conference Call March 13, 2024 8:00 AM ET Company Participants Mary Chen - Director of Investor Relations Donald Dunde Yu - Founder, Chairman and Chief Executive Officer Anqiang Chen - Financial Controller Conference Call Participants Rita Lee - Private Investor Operator Hello and thank you for standing by for Tuniu's 2023 Fourth Quarter and Full Year Earnings Conference Call. At this time, all participants are in a listen-only mode. After management's prepar ...
Tuniu to Report Fourth Quarter and Fiscal Year 2023 Financial Results on March 13, 2024
PRNewsWire· 2024-03-01 06:00
NANJING, China, March 1, 2024 /PRNewswire/ -- Tuniu Corporation (NASDAQ:TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today announced that it plans to release its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023, before the market opens on March 13, 2024.Tuniu's management will hold an earnings conference call at 8:00 am U.S. Eastern Time on March 13, 2024 (8:00 pm Beijing/Hong Kong Time on March 13, 2024).Listeners may access t ...
Tuniu(TOUR) - 2023 Q3 - Earnings Call Transcript
2023-11-21 15:49
Tuniu Corporation (NASDAQ:TOUR) Q3 2023 Results Conference Call November 21, 2023 8:00 AM ET Company Participants Mary Chen - Director, Investor Relations Donald Yu - Founder, Chairman and Chief Executive Officer Anqiang Chen - Financial Controller Operator Hello, and thank you for standing by for Tuniu’s 2023 Third Quarter Earnings Conference Call [Operator Instructions]. Today's conference is being recorded. If you have any objections, you may disconnect at this time. I would now like to turn the meeting ...
Tuniu(TOUR) - 2023 Q2 - Earnings Call Transcript
2023-08-17 13:35
Tuniu Corporation (NASDAQ:TOUR) Q2 2023 Earnings Conference Call August 17, 2023 8:00 AM ET Company Participants Mary Chen - Investor Relations Director Donald Dunde Yu - Founder, Chairman and Chief Executive Officer Anqiang Chen - Financial Controller Conference Call Participants Rachel Lee - Private Investor Operator Good day, and welcome to the Tuniu ‘23 Q2 Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to as ...